These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 24412751)

  • 41. Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies.
    Ettenberg SA; Charlat O; Daley MP; Liu S; Vincent KJ; Stuart DD; Schuller AG; Yuan J; Ospina B; Green J; Yu Q; Walsh R; Li S; Schmitz R; Heine H; Bilic S; Ostrom L; Mosher R; Hartlepp KF; Zhu Z; Fawell S; Yao YM; Stover D; Finan PM; Porter JA; Sellers WR; Klagge IM; Cong F
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15473-8. PubMed ID: 20713706
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Wnt3a-stimulated LRP6 phosphorylation is dependent upon arginine methylation of G3BP2.
    Bikkavilli RK; Malbon CC
    J Cell Sci; 2012 May; 125(Pt 10):2446-56. PubMed ID: 22357953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reconstitution of a frizzled8.Wnt3a.LRP6 signaling complex reveals multiple Wnt and Dkk1 binding sites on LRP6.
    Bourhis E; Tam C; Franke Y; Bazan JF; Ernst J; Hwang J; Costa M; Cochran AG; Hannoush RN
    J Biol Chem; 2010 Mar; 285(12):9172-9. PubMed ID: 20093360
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Frizzled and LRP5/6 receptors for Wnt/β-catenin signaling.
    MacDonald BT; He X
    Cold Spring Harb Perspect Biol; 2012 Dec; 4(12):. PubMed ID: 23209147
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Opposing Roles of Wnt Inhibitors IGFBP-4 and Dkk1 in Cardiac Ischemia by Differential Targeting of LRP5/6 and β-catenin.
    Wo D; Peng J; Ren DN; Qiu L; Chen J; Zhu Y; Yan Y; Yan H; Wu J; Ma E; Zhong TP; Chen Y; Liu Z; Liu S; Ao L; Liu Z; Jiang C; Peng J; Zou Y; Qian Q; Zhu W
    Circulation; 2016 Dec; 134(24):1991-2007. PubMed ID: 27803037
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR-/- mice by restraining noncanonical Wnt signals.
    Cheng SL; Ramachandran B; Behrmann A; Shao JS; Mead M; Smith C; Krchma K; Bello Arredondo Y; Kovacs A; Kapoor K; Brill LM; Perera R; Williams BO; Towler DA
    Circ Res; 2015 Jul; 117(2):142-56. PubMed ID: 26034040
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PTK7 modulates Wnt signaling activity via LRP6.
    Bin-Nun N; Lichtig H; Malyarova A; Levy M; Elias S; Frank D
    Development; 2014 Jan; 141(2):410-21. PubMed ID: 24353057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of the canonical Wnt pathway by high glucose can be reversed by parathyroid hormone-related protein in osteoblastic cells.
    López-Herradón A; Portal-Núñez S; García-Martín A; Lozano D; Pérez-Martínez FC; Ceña V; Esbrit P
    J Cell Biochem; 2013 Aug; 114(8):1908-16. PubMed ID: 23494914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The low density lipoprotein receptor-1, LRP1, interacts with the human frizzled-1 (HFz1) and down-regulates the canonical Wnt signaling pathway.
    Zilberberg A; Yaniv A; Gazit A
    J Biol Chem; 2004 Apr; 279(17):17535-42. PubMed ID: 14739301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mesd is a universal inhibitor of Wnt coreceptors LRP5 and LRP6 and blocks Wnt/beta-catenin signaling in cancer cells.
    Lu W; Liu CC; Thottassery JV; Bu G; Li Y
    Biochemistry; 2010 Jun; 49(22):4635-43. PubMed ID: 20446724
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sequence and structural difference favors a distinct preference of Wnt3a binding with co-receptor LRP6.
    Sahu I; Mishra S; Undi R; Kandi R; Gutti U; Gutti RK
    J Biomol Struct Dyn; 2015; 33(10):2133-44. PubMed ID: 25425204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Wnt- and glutamate-receptors orchestrate stem cell dynamics and asymmetric cell division.
    Junyent S; Reeves JC; Szczerkowski J; Garcin CL; Trieu TJ; Wilson M; Lundie-Brown J; Habib SJ
    Elife; 2021 May; 10():. PubMed ID: 34028355
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Wnt3a suppresses Wnt/β-catenin signaling and cancer cell proliferation following serum deprivation.
    He Q; Yan H; Wo D; Liu J; Liu P; Zhang J; Li L; Zhou B; Ge J; Li H; Liu S; Zhu W
    Exp Cell Res; 2016 Feb; 341(1):32-41. PubMed ID: 26643293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pertussis toxin-sensitive heterotrimeric G(αi/o) proteins mediate WNT/β-catenin and WNT/ERK1/2 signaling in mouse primary microglia stimulated with purified WNT-3A.
    Halleskog C; Schulte G
    Cell Signal; 2013 Apr; 25(4):822-8. PubMed ID: 23266471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reporter gene HEK 293 cells and WNT/Frizzled fusion proteins as tools to study WNT signaling pathways.
    Ring L; Peröbner I; Karow M; Jochum M; Neth P; Faussner A
    Biol Chem; 2011 Nov; 392(11):1011-20. PubMed ID: 21864196
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of canonical Wnt signaling by the extracellular matrix component biglycan.
    Berendsen AD; Fisher LW; Kilts TM; Owens RT; Robey PG; Gutkind JS; Young MF
    Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17022-7. PubMed ID: 21969569
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiopoietin-like 4 Is a Wnt Signaling Antagonist that Promotes LRP6 Turnover.
    Kirsch N; Chang LS; Koch S; Glinka A; Dolde C; Colozza G; Benitez MDJ; De Robertis EM; Niehrs C
    Dev Cell; 2017 Oct; 43(1):71-82.e6. PubMed ID: 29017031
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Negative regulation of LRP6 function by casein kinase I epsilon phosphorylation.
    Swiatek W; Kang H; Garcia BA; Shabanowitz J; Coombs GS; Hunt DF; Virshup DM
    J Biol Chem; 2006 May; 281(18):12233-41. PubMed ID: 16513652
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New explanation for autosomal dominant high bone mass: Mutation of low-density lipoprotein receptor-related protein 6.
    Whyte MP; McAlister WH; Zhang F; Bijanki VN; Nenninger A; Gottesman GS; Lin EL; Huskey M; Duan S; Dahir K; Mumm S
    Bone; 2019 Oct; 127():228-243. PubMed ID: 31085352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.